Neurogastrx believes its drug could treat one of the most troublesome side effects of one of the industry's biggest blockbusters. On Wednesday, the Boston-area biotech said that its experimental drug ...

Further, the company expected the market to grow significantly in the coming years. Further, the company is also developing ...

A woman who takes weight loss medication has called Health Secretary Wes Streeting “naive” after he suggested weight-loss ...

A weight-loss drug more effective than Ozempic and Wegovy has recently been approved in Australia.Authors Paul Joyce ...

Support for people living with obesity is “insufficient”, experts have said after a new report revealed that some patients are being asked to wait for up to five years for specialist support. Some ...

A global survey of breast cancer patients reveals a gap in support services for managing the mental and physical side effects experienced by those undergoing treatment.

A review of the medical records of thousands of adolescents treated for obesity found that kids who received the GLP-1 ...

Tirzepatide, a cutting-edge medication initially approved for the treatment of type 2 diabetes, has shown remarkable potential in facilitating significant weight loss. This dual GIP and GLP-1 receptor ...

Providing coverage for weight-loss drugs such as Wegovy and Ozempic is forcing employers to make some critical decisions.

Fat Joe opens up about his impressive 200-pound weight loss, revealing whether Ozempic played a role in his transformative ...

Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...

The company has committed £279 million ($364 million) to support national efforts aimed at reducing obesity, a critical ...